Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Bofanglutide

GZR18-BWM-303

Gan & Lee Pharmaceuticals · Phase 3 · Recruiting · Enrollment 500

NCT07292441

ArmPopulationDoseWeeksEstimandWeight change
PlaceboObesity or overweightn/r2n/rn/r
GZR18 injection Dose1Obesity or overweightn/r2n/rn/r
GZR18 injection Dose2Obesity or overweightn/r2n/rn/r
GZR18 injection Dose3Obesity or overweightn/r2n/rn/r